| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |